CRISPR Therapeutics $2.4 Billion Cash: Why the Stock Slump Persists
CRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Adopt weekly routines that promote financial health and stability. These simple practices can lead to significant improvements in your finances.
18,596 articlesCRISPR Therapeutics wields a rare card: a cash-rich balance sheet and an approved gene therapy. But the stock refuses...
Upstart has stunned the market with a renewed focus on AI-powered lending, but questions remain. This article breaks ...
Aurora Cannabis faces a pivotal year in 2026. This guide breaks down what to expect in aurora (acb) 2026 earnings, ho...
A federal judge invalidated the White House’s $100,000 H-1B filing fee, creating immediate uncertainty for U.S. emplo...
In a hypothetical mid-June scenario, SpaceX launches a historic $1.75 trillion IPO, raising $85.7 billion and closing...
Looking for steady income from your investments? Explore two industrial stocks growing dividends that blend resilienc...
Netflix has cooled off, and rumors about Warner Bros. and Roku fueled debate. This guide analyzes whether the pullbac...
Ten years after the Brexit vote, Britain faces political churn and stubborn economic headwinds. Seven prime ministers...
Palantir has a unique data platform and government-commercial mix. This guide outlines how the business could evolve,...
An accessible analysis of what this $405,000 bj's insider sale means for investors, plus practical steps to read insi...
US-focused Altria or global leader Philip Morris International? This guide breaks down the strategy, dividends, and g...
Early data from the 2026 World Cup in the U.S. shows host-city spending rising while visitor demand surges, challengi...